Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002392397 | SCV002708614 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-10-15 | criteria provided, single submitter | clinical testing | The c.1042_1069dup28 pathogenic mutation, located in coding exon 6 of the MSH2 gene, results from a duplication of 28 nucleotides at position 1042, causing a translational frameshift with a predicted alternate stop codon (p.E357Afs*6). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |